Jonas, J. B. (2018). Reply to the letter by Hall entitled “ILUVIEN in diabetic macular edema: The choice of second-line corticosteroid should be left to the clinical judgement of the treating physician”. Ophthalmologica, 239(4), . https://doi.org/10.1159/000481737
Chicago Style (17th ed.) CitationJonas, Jost B. "Reply to the Letter by Hall Entitled “ILUVIEN in Diabetic Macular Edema: The Choice of Second-line Corticosteroid Should Be Left to the Clinical Judgement of the Treating Physician”." Ophthalmologica 239, no. 4 (2018). https://doi.org/10.1159/000481737.
MLA (9th ed.) CitationJonas, Jost B. "Reply to the Letter by Hall Entitled “ILUVIEN in Diabetic Macular Edema: The Choice of Second-line Corticosteroid Should Be Left to the Clinical Judgement of the Treating Physician”." Ophthalmologica, vol. 239, no. 4, 2018, https://doi.org/10.1159/000481737.